PFS - Provident Financial Services, Inc.
Inhibrx is transitioning from a platform to a clinical-stage biotech, with ozekibart and INBRX-106 as key value drivers. Ozekibart's BLA for chondrosarcoma is under FDA review with an April 14, 2027 PDUFA date, supported by strong PFS and disease control data. INBRX-106 shows promising early efficacy as a PD-1 enhancer in HNSCC, with pivotal PFS data expected in Q4 2026 and Phase 3 initiation in Q3 2026.
ISELIN, N.J., July 15, 2026 (GLOBE NEWSWIRE) -- Provident Bank, a leading New Jersey-based financial institution, announced today that Anthony Petrazzuoli has joined the bank as Senior Vice President, Deposit & Payments Operations Director.
WHITE SULPHUR SPRINGS, Mont., July 09, 2026 (GLOBE NEWSWIRE) -- Sandfire Resources America Inc. ("Sandfire America" or the "Company") is pleased to announce the results of an updated Preliminary Feasibility Study ("PFS") for the Black Butte Copper Project (the “Project” or “Black Butte Copper”) that significantly enhances the Project's long-term value through the inclusion of the nearby Lowry copper deposit (the "Lowry Deposit") in the mine plan. The updated PFS results position the Black Butte Copper Project as one of the highest-grade undeveloped underground copper projects in the United States.
ISELIN, N.J., July 01, 2026 (GLOBE NEWSWIRE) -- Provident Financial Services, Inc. (NYSE: PFS) announced that it expects to release financial results for the quarter ended June 30, 2026 on Wednesday, July 29, 2026 after market close. A copy of the earnings release will be immediately available on the Company's website, www.Provident.Bank, by going to Investor Relations and clicking on Press Releases.
Toronto, Ontario--(Newsfile Corp. - June 25, 2026) - Tartisan Nickel Corp. (CSE: TN) (OTCQX: TTSRF) (FSE: 8TA) ("Tartisan", or the "Company") is pleased to announce that it has engaged Tetra Tech Canada Inc. (Tetra Tech) to conduct an independent review of the existing Preliminary Economic Assessment (PEA) for the Kenbridge Nickel-Copper-Cobalt Project and deliver a structured Goal-Actual-Plan Analysis (GAP) identifying the technical, commercial, and compliance work required to advance the Kenbridge Project to the Pre-Feasibility Study (PFS) level. The Tetra Tech Team will preform a PFS GAP Analysis and prepare a Technical Memorandum for Tartisan's Internal use that includes the outcomes of the following services: Assess the quality, completeness and assumptions of the current PEA Identify gaps relative to PFS requirements (technical, data, and test work) Prioritise gaps and recommend a staged work program with cost/time estimates to close them.
Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) approved IBRANCEÂ (palbociclib) in combination with trastuzumab, with or w
Today, American Ocean Minerals Corporation (AOMC) announced the successful completion of Expedition 7, a research campaign designed to support the environmenta
ISELIN, N.J., June 23, 2026 (GLOBE NEWSWIRE) -- Provident Bank, a leading New Jersey-based financial institution, announced today the appointment of Adriano Duarte to Executive Vice President and Chief Financial Officer of Provident Bank and Provident Financial Services, Inc. (NYSE: PFS), effective July 1, 2026.
AbbVie Announces European Commission Approval of SKYRIZIÂ (risankizumab) for the Treatment of Pediatric Patients with Moderate to Severe Plaqu
Expanded programs targeting Q1 CY27 completion & ML application HIGHLIGHTS GR Engineering appointed to lead Pre-feasibility Study (PFS) for Tunkillia Gold Project; targeting Q1 CY27 PFS completion to include prospective Resource upside in open pit optimisations Ongoing upgrade drilling has already infilled highest value ‘S1' and ‘S2' optimised open pit areas with broad, high-grade mineralisation and identified higher-grade extensions of ‘Area 51' open pit area; Phase 2 drilling has now expanded, targeting Resources and grade upside mineralisation in open pits[1] ADELAIDE, AUSTRALIA / ACCESS Newswire / June 21, 2026 / Barton Gold Holdings Limited (ASX:BGD)(OTCQB:BGDFF)(FRA:BGD3) (Barton or Company) is pleased to announce that a Pre-Feasibility Study (PFS) has started for its South Australian Tunkillia Gold Project (Tunkillia). GR Engineering Services Limited (GRES) has been appointed to lead the PFS.
Funds will be used to support revitalization plans for distressed neighborhoods Funds will be used to support revitalization plans for distressed neighborhoods
Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited
[url="]Genmab A/S[/url] (Nasdaq: GMAB) today announced new data from two studies evaluating epcoritamab, a T-cell engaging antibody administered subcutaneously
New TALVEYÂ (talquetamab-tgvs) plus DARZALEX FASPROÂ (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combi
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (MonjuviÂ/Min
[url="]BeOne Medicines Ltd.[/url] (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced the presentation of a large Phase 3 datas
[url="]The Schall Law Firm[/url], a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Regeneron P
WuXi Biologics Singapore CRDMO Hub Completes Modular Topping-Out of Drug Product Facility PR Newswire SINGAPORE,
Seasoned Wealth Management Executive to Lead Strategic Growth of Provident Bank's Wealth Management Business Seasoned Wealth Management Executive to Lead Strategic Growth of Provident Bank's Wealth Management Business
Further positive results from the Phase III SERENA-6 trial showed AstraZeneca's camizestrant plus a cyclin-dependent kinase (CDK) 4/6 inhibitor â palbociclib